Variant Summary
- Also known as
- SNX2-ABL1
- HGVS
- —
- Variant Type(s)
- transcript_fusion
- Evidence Items
- 7
Evidence Level Distribution
Level C: 6Level D: 1
Evidence Items
Showing CIViC evidence rows where gene = SNX2::ABL1 and variant = Fusion.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Resistance | B-lymphoblastic Leukemia/lymphoma | Imatinib,Dasatinib | 3 |
| C | Diagnostic | Supports | Positive | B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like | 3 | |
| C | Diagnostic | Supports | Positive | B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like | 3 | |
| C | Predictive | Supports | Resistance | B-lymphoblastic Leukemia/lymphoma | Dasatinib | 2 |
| C | Predictive | Supports | Reduced Sensitivity | B-lymphoblastic Leukemia/lymphoma | Imatinib | 1 |
| C | Prognostic | Supports | Poor Outcome | B-lymphoblastic Leukemia/lymphoma | 1 | |
| C | Prognostic | Supports | Poor Outcome | B-lymphoblastic Leukemia/lymphoma | 1 |